0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query mrrpb5 global biosimilars treatment market size status forecast 2019 2025.Your search for "" gave back 1533058 results.
North America biosimilars market is expected to grow by 25.1% annually in the forecast period and reach $27.57 billion by 2030 driven by the...
Catalog:
Grace Market Data
November 2021
Price: USD 2,700.00
Europe biosimilars market was valued at $5,847.6 million in 2020 and will grow by 23.1% annually over 2020-2030 owing to the affordability of...
Catalog:
Grace Market Data
November 2021
Price: USD 2,700.00
Asia Pacific biosimilars market will grow by 30.7% annually with a total addressable market cap of $140.4 billion over 2021-2030 owing to the...
Catalog:
Grace Market Data
November 2021
Price: USD 2,700.00
Global biosimilars market will reach $113.25 billion by 2030, growing by 25.7% annually over 2020-2030 driven by the affordability of biosimilar-...
Catalog:
Grace Market Data
November 2021
Price: USD 3,200.00
The global Biosimilar Monoclonal Antibody market size was valued at US$ 4411.1 million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
March 2024
Price: USD 3,660.00
The global Biosimilar Testing and Development Services market size was valued at US$ million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
March 2024
Price: USD 3,660.00
The global Biosimilar market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar is forecast to a...
Catalog:
LPI
January 2024
Price: USD 3,660.00
The global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics...
Catalog:
LPI
January 2024
Price: USD 3,660.00
The global Microscopic Polyangiitis (MPA) Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Human insulin is the name which describes synthetic insulin which is laboratory grown to mimic the insulin in humans. The global Human Insulin market...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
A thrombolytic drug is a type of medication designed to dissolve blood clots. These drugs work by activating the body's natural clot-dissolving...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Granulomatosis with Polyangiitis (Wegener Polyangiitis) - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and...
Catalog:
Global Markets Direct
May 2019
Price: USD 2,000.00
Microscopic Polyangiitis (MPA) - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
Catalog:
Global Markets Direct
August 2019
Price: USD 2,000.00
Macular Edema - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Macular...
Catalog:
Global Markets Direct
June 2020
Price: USD 2,000.00
